| Literature DB >> 33586486 |
Samuel Akyirem1,2, Angus Forbes1, Julie Lindberg Wad3, Mette Due-Christensen1,3.
Abstract
While the need for psychosocial interventions in the early formative period of chronic disease diagnosis is widely acknowledged, little is known about the currently available interventions and what they entail. This review sought to collate existing interventions to synthesize their active ingredients. A systematic search on five electronic databases yielded 2910 records, 12 of which were eligible for this review. Evidence synthesis revealed three broad categories of interventions which used at least two out of eight active techniques. Future studies should adhere to known frameworks for intervention development, and focus on developing core outcome measures to enhance evidence synthesis.Entities:
Keywords: adaptation; chronic disease; coping; newly diagnosed; psychosocial intervention; social support
Mesh:
Year: 2021 PMID: 33586486 PMCID: PMC9092922 DOI: 10.1177/1359105321995916
Source DB: PubMed Journal: J Health Psychol ISSN: 1359-1053
Facet analysis of review question.
| Population 1 | Population 2 | Intervention | |
|---|---|---|---|
| Index term (exploded) | HIV/AIDS | – | Psychosocial support |
| Rheumatoid arthritis | Psychotherapy | ||
| Multiple sclerosis | Psychoeducation | ||
| Type 1 diabetes mellitus | Patient support | ||
| Type 2 diabetes mellitus | Acceptance and commitment therapy | ||
| Inflammatory bowel disease | Cognitive behavioural therapy | ||
| Free text, synonyms, alternative spelling and abbreviations | HIV infection | Recent diagnosis | CBT |
| Retroviral infection | New onset | ACT | |
| Rheumatism | New diagnosis | Patient education | |
| Crohn’s disease | Recently diagnosed | Acceptance | |
| Ulcerative colitis | Newly diagnosed | Commitment | |
| T1D, T2D, PLWH, PLWHA, IBD | After diagnosis |
Figure 1.PRISMA chart (Moher et al., 2009).
Studies excluded for other reasons.
| Studies | Reasons for exclusion |
|---|---|
|
| The intervention described in this study appeared to have a psychosocial component. The focus, however, was on increasing self-management skills. |
|
| A pilot study. The main study which was conducted in 2017 was included in this review instead. |
|
| This study was about a suicide prevention intervention that seemed too specific and peculiar to HIV. It was excluded based on its relevance to the overarching objective of this review. |
| The studies evaluated intervention by a medical social worker. Different types of tailored psychosocial interventions were used but studies provided no details of such interventions. Therefore, they could not contribute to the overarching objective of this review. | |
| These two studies represent a case series (2001) and the 2-year follow-up (2003) reports of a 2001 study (included in this review). The follow-up report provided data on the long-term impact of the psychosocial intervention. However, the lack of intention-to-treat analysis and inconsistencies with the main 2001 study led to its exclusion from this review. | |
|
| Non-adult participants (<18 years) were included in this study |
|
| This study describes a nurse coaching intervention aimed at increasing adherence to dietary and lifestyle modification following an educational programme. Excluded for its focus on lifestyle changes and no clear psychological component. |
Summary of evidence.
| First author, (year), country, design | Objective | Sample characteristics | Intervention/underlying theory | Active ingredients or mechanism of action | Major findings | Additional comments | Quality assessment |
|---|---|---|---|---|---|---|---|
| Spiess (1995), Austria, RCT | To determine the impact of a distress reduction intervention on psychosocial variables and the association between adaptation and HbA1c | T1D with DD (m, SD) = 4.3 (4.2) weeks; IG:
| Onset distress reduction programme – group
format, psychotherapist-led and having a total of 25
90 minutes-sessions + self-management
education | Emotional and grief expressionAddressing anxieties regarding late complications.Challenges of living with diabetes as well as the impact on social and family life and coping strategiesCognitive restructuring | HbA1c improved in IG/CG groups (6.9%/6.6%) at 15 months follow up with no significant difference between groups.Depression, anxious coping and denial score improved at 9 months in the intervention group only (p<0.01). | 90% attended between 13 and 23 groups sessions. Participants in group sessions not stratified by, for instance, age group | Moderate |
| At 15 months, the effects of all psychosocial measures in the intervention group had faded sparing denial. | |||||||
| Mundell (2011), South Africa, Quasi-experimental | To assess the impact of a psychosocial support group on pregnant HIV positive women | HIV with DD (m, SD): 13.97 (46.02) weeks; IG:
| Support group – psychology students-led, and having a total of 10 sessions | Education on HIV and its emotional impact. Addressing relational issues such as disclosure, stigma and discrimination. Coping strategies and stress management were addressed. Life planning and goal setting | Accelerated increase in coping (MD-2.68,
| Improvement was based on attendance as those who attended five or more sessions had better outcomes. Therapists were trained and intervention fidelity ensured | Moderate |
|
| |||||||
| To determine the feasibility and acceptability of an acceptance-based intervention and its impact on experiential avoidance. | HIV with DD (m, SD) = 84.7 (76.3) days;
| Acceptance-Based Behaviour therapy (ABBT) – individual format, clinical psychologist-led, having a total of two sessions and lasting for 15–20 minutes each | Psychoeducation. Cognitive defusion and experiential acceptance techniques. Focus on life goals to provide a sense of coherence for patients. | HIV acceptance increased from baseline to 1-month follow-up (MD on the AAQ scale– 4.21). Also, reductions in depressive symptoms (MD on PHQ scale – 0.38), HIV health care system distrust and stigmatization (MD on HSS scale – 1) were detected post-intervention. | Three participants refused the intervention because they felt too emotionally distressed about their new diagnosis. [how long after diagnosis is it appropriate to start intervention?] | Low | |
|
| |||||||
| Sharpe (2001), UK, RCT | To investigate whether a CBT applied within the first 2 years of illness could be effective in reducing psychological morbidity in RA patients | RA with DD (m, SD) – 12.6 (14.1) months; IG:
| CBT – individual format, psychologist-led and having a total of eight 1 hour sessions + Routine medical care | An educational component on the management of flare-ups or high-risk situations, Self-management skills, Relaxation training, attention diversion, goal setting, pacing, problem-solving, cognitive restructuring and enhancing communication skills. | Clinically significant improvements in HADS
scores in IG (17% to 4% decrease in ‘possible cases of
depression’ in this group). Non-significant changes in
anxiety were observed ( | Treatment manual used. Dropouts were younger, more depressed and had a higher level of joint dysfunction than those completing treatment. | Moderate |
|
| |||||||
| To assess pre-post mental health outcomes of CBT for gay men recently diagnosed HIV patients | HIV with DD (median): 66 days;
| CBT – individual format, psychologist-led and
having a total of three sessions of unspecified
lengths. | Relaxation techniques, cognitive restructuring, problem-solving and keeping automatic thought records to keep track of negative thoughts. | Significant improvements in depression (Cohen’s
| Text messages used to remind participants of sessions. Intervention fidelity was ensured. | Low | |
| Brashers (2017), USA, RCT | To assess the efficacy of peer support intervention designed to improve uncertainty management and psychosocial functioning for patients newly diagnosed with HIV | HIV with DD (IG/CG): 1.5/1.8 years; IG:
| Uncertainty management intervention – peer educator-led,
unclear format, with a total of six 1 hour
sessions | Psychoeducation. Where and how to find pertinent information. Effective communication with family, friends and healthcare workers | A decline in illness uncertainty in the IG compared to the CG was observed at all follow-up periods. No improvement was seen in the perceptions of available social support. Improvement in depression scores was seen in IG whereas those in the CG experienced no significant change in depression over time. Self-advocacy did not change in either group. | Peer educators were trained before the intervention. Participant reimbursements were used to attract information avoiders to participate | Low |
| Calandri (2017), Italy, Quasi-experimental | To evaluate a group-based cognitive behavioural intervention to promote the quality of life and psychological well-being of patients with newly diagnosed MS. | MS with DD (IG/CG) – 1.5/1.8 years, IG:
| CBT – group format, psychologist-led and having five 2 hour sessions with additional sessions at 6- and 12-months follow-up periods | Relaxation exercises. Exploring identity change and redefinition of life goals. Goal setting, managing symptoms and illness-related negative emotions. Cognitive restructuring, effective, communication and homework assignment. | At 6 months, the mental health component of QoL
increased in IG ( | The intervention group was stratified by age-groups to facilitate the sharing of similar experiences. Each session had a 15 minutes break | Moderate |
|
| |||||||
| Visschedijk (2004), Netherland, Quasi-experimental | To estimate the effect of a cognitive-behavioural based group intervention programme on health-related quality of life in patients with MS | MS with DD – <3 years,
| CBT – group format, psychologist-led and having a total of eight 2 hour sessions. | Moving on after diagnosis, self-management, efficient communication with family, friends and medical staff. Coping with psychological distress, uncertainty and fear | Improvement in psychological status (ES – 0.29,
| Two patients dropped out because confrontation with other patients in a group setting was too distressing for them. | Low |
|
| |||||||
| Moskowitz (2017), USA, RCT | To determine the impact of positive affect intervention on positive emotion, psychological health, physical health and health behaviours in people newly diagnosed with HIV. | HIV with DD – 2 months, IG:
| Positive affect intervention – individual
format, led by facilitators with experience in public health
research. A total of five 1 hour sessions in addition to a
follow-up phone call on week 6. | Positive reappraisal, benefit finding and capitalizing on the positives of the disease. Eliciting positive feelings by showing gratitude and being kind to others despite physical limitations. Relaxation techniques such as mindfulness. | No significant change in negative affect and CD4
in IG/CG at 15 months. Intrusive and avoidant thoughts
improved more in IG than CG (ES – 0.29,
| 72% retention rate despite reimbursing participants for attending treatment and assessment sessions. | Moderate |
| Therapists were extensively trained, and intervention fidelity was ensured. | |||||||
| Kiropoulos (2016), Australia, RCT | To examine the effectiveness and acceptability of a tailored CBT intervention for the treatment of depressive symptoms in those newly diagnosed with MS. | MS with DD (IG/CG) – 26.2/23.53 months; IG:
| CBT – individual format, psychologist-led, with eight sessions lasting between 1 and 1.5 hours each | Progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem-solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs. Homework for each session to reinforce learned skills | CBT group had significantly lower depression scores at post-treatment (ES = 1.66) and at 20 weeks follow up (ES = 1.34) compared to the CG. Anxiety was lower in the CBT group though non-significant. Physical (ES – 0.7) and mental health (ES – 1) components of QoL were significantly higher in the CBT group than TAU at 20 weeks | A therapy manual was used. | Moderate |
|
| |||||||
| Molton (2019), USA, RCT | To develop and test a brief intervention designed to improve the ability to tolerate uncertainty and to improve MS acceptance in individuals in the early phases of MS | MS with DD – 376.3 days; IG:
| Psychological Intervention led by ‘study clinician’, delivered in an individual format and comprising six sessions. | General education, Mindfulness/thought awareness to enable patients to deal with rumination and catastrophizing. Managing the controllable and accepting the uncontrollable aspects of MS. Empowering patients to focus on their life goals/values and to pursue them despite their chronic disease. | Postintervention, those in the intervention
group demonstrated lower levels of IU (Cohen’s
| A treatment manual was used. Strategies to increase participation included use of a few sessions and the option to receive treatment either via face-to-face or telephone | Moderate |
|
| |||||||
| Brusadelli (2018), Italy, Unclear | To evaluate the effects of psychological intervention on HbA1c and psychosocial outcomes in newly diagnosed T2DM | T2D with DD <12 months;
| CBT-like intervention, group format, psychologist-led, with six 90 minutes sessions | psychoeducation (including recommendations for a healthy lifestyle and diet), problem-solving, cognitive restructuring and enhancement of emotional communication. | Higher clinically significant improvement in
HbA1c was seen in IG ( | – | Low |
|
|
IG: intervention group; CG: control group; m, SD: mean, standard deviation; N/R: Not reported; T1D: Type 1 diabetes; T2D: Type 2 diabetes; RA: Rheumatoid arthritis; MS: Multiple sclerosis; HbA1c: Glycated haemoglobin; DD: disease duration; ES: effect-size; CBT: cognitive behavioural therapy; MD: mean difference; ESR: Erythrocytes sedimentation rate; TAU: treatment as usual: HADS: Hospital anxiety depression scale; HSS: HIV Stigma Scale; PHQ: Patient health questionnaire; GAD-7: general anxiety scale; QoL: Quality of life; AAQ: Acceptance and Action Questionnaire; EDSS: Expanded Disability Status Scale.
Active ingredients of psychosocial intervention.
| Brashers et al. | Brusadelli et al. | Calandri et al. | Kiropoulos et al. | Moskowitz et al. | Moitra et al. | Moltron et al. | Mundel et al. | Sharpe et al. | Spiess et al. | Visschedijk et al. | Yang et al. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| CBT or CBT-like | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Uncertainty management | ✓ | |||||||||||
| Social support | ✓ | |||||||||||
| Active techniques | ||||||||||||
| Education | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| Communication development | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Relaxation techniques | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Cognitive restructuring | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Homework | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
| Problem-solving | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
| Acceptance and finding meaning | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
| Goal setting | ✓ | ✓ | ✓ | |||||||||
| Timing of intervention | ||||||||||||
| Brief | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Long-term | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
| Location | ||||||||||||
| Medical | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Non-medical | ✓ | |||||||||||
| Therapist | ||||||||||||
| Psychologist | ✓ | ✓ | ✓ | ✓ | ✓
| ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Non-psychologist | ✓ | |||||||||||
| Peer educator | ✓ | |||||||||||
| Mode of delivery | ||||||||||||
| Individual | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
| Group (N per group) | ✓ (12) | ✓ (4–10) | ✓ (10) | ✓ (10) | ✓ (7) | |||||||
| Outcomes (with significant improvements) | ||||||||||||
| Physical | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
| Psychological | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Affective | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Social | ✓ | ✓ | ✓ | ✓ | ||||||||
Cells highlighted in black indicate particular component was not reported.
Reported as ‘study clinician’.
No significance test conducted.
Questionnaires used for measuring psychosocial outcomes.
| No. | Questionnaire | References | Outcome measured | Description | Studies in which they were used |
|---|---|---|---|---|---|
| 1 | Center for Epidemiologic Studies Depression Scale (CES-D) |
| Depression | A 20-item scale designed to assess depressive symptoms (past week) in the general population, rather than in the population of people clinically diagnosed with depression | |
| 2 | 10-item Center for Epidemiologic Studies Depression Scale (CES-D-10). |
| Depression | A short version of the 20-item CES-D. The CES-D-10 measures the frequency of depressive symptoms during the past week | Calandri et al. (2017) |
| 3 | Beck Depression Inventory-I/II (BDI) |
| Depression | This is a 21-item self-reporting questionnaire for evaluating the severity of depression in normal and psychiatric populations | |
| 4 | Patient Health Questionnaire (PHQ-9) |
| Depressive symptoms | The 9-item PHQ-9 was specifically developed for use in primary care settings for making diagnosis of depression in such settings. | |
| 5 | Hospital Anxiety Depression Scale (HADS) |
| Anxiety and depression | A 14-item questionnaire developed to assess anxiety and depression in patients with physical health problems | |
| 6 | State Trait Anxiety Inventory (STAI) |
| Anxiety | The 20-item STAI evaluates feelings of tension, nervousness, worry and apprehension ‘in the past 2 weeks, including today’ with higher scores reflecting higher severity | |
| 7 | Generalized Anxiety Disorder – 7 (GAD-7) |
| Global anxiety | This questionnaire is a 7-item, self-report anxiety questionnaire designed to screen and assess the severity of generalized anxiety during the previous 2 weeks. |
|
| 8 | Positive Affect Negative Affect Schedule (PANAS) |
| Positive affect, negative affect | The schedule constitutes two mood scales, one measuring Positive Affect (PA) (10 items) and the other measuring Negative Affect (NA) (10 items) | Calandri et al (2017) |
| 9 | Differential Emotions Scale (DES) |
| Positive and negative affect | Assesses nine positive emotions (amused, awe, content, glad, grateful, hopeful, interested, love and pride) and eight negative emotions (angry, ashamed, contempt, disgust, embarrassed, repentant, sad and scared) |
|
| 10 | Life Orientation Test-Revised (LOT-R) |
| Optimism | The test comprises 10 items (three items framed in a positive way, three items framed in a pessimistic way and four fillers to disguise the purpose of the test). It measures future expectations that are either positive or negative | Calandri et al (2017) |
| 11 | Ways of Coping Questionnaire (WCQ) |
| Coping | The 66-item tool consists of eight scales measuring confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem-solving and positive reappraisal. |
|
| 12 | Brief Coping Orientation to Problems Experienced (Brief COPE) |
| Coping | This tool has 14 subscales that assess acceptance, emotional social support, humour, positive reframing, religion, active coping, instrumental support, planning, behavioural disengagement, denial, self-distraction, self-blaming and substance use and venting. |
|
| 13 | Coping Strategy Questionnaire (CSQ) |
| Coping strategies | It includes seven subscales – two involve maladaptive strategies and the remaining five involve adaptive strategies. A total score of active coping is calculated by subtracting the passive scale scores from the sum of the active scale. |
|
| 14 | Brief Adjustment Scale (BASE-6) |
| Problems in psychological adjustment | It assesses emotion distress (depression, anxiety and anger) and related interference (impact on self-esteem, personal relationships and occupational functioning) |
|
| 15 | Illness Uncertainty Scale (IUS) |
| Uncertainty | Evaluates the three aspects of uncertainty experience: ambiguity, complexity and deficiency of information |
|
| 16 | Intolerance of Uncertainty scale |
| Intolerance of uncertainty | This 27 items instrument is related to the idea that uncertainty is unacceptable, leads to frustration and creates an inability to take action. |
|
| 17 | Hackett-Cassem Denial Scale |
| Denial | 31-item scale used to quantify denial traits and to classify individuals into mild, moderate and major deniers |
|
| 18 | Acceptance of Chronic Health Conditions Scale (ACHC) |
| Acceptance or psychological flexibility | The 10-item ACHC scale measures acceptance to chronic disease | |
| 19 | Acceptance and Action Questionnaire–II measure (AAQ-II) |
| Acceptance | The AAQ-II assesses general psychological acceptance, emotional willingness and tendency to engage in experiential avoidance |
|
| 20 | 33-item Resilience Scale for Adults (RSA) |
| Resilience | The 33 items in the scale cover six dimensions namely: Perception of self, Planned future, Social competence, Structured style, Family cohesion, Social resources |
|
| 21 | Social Support Scale (SSS) |
| Social support | This 6-item scale assesses the number of supportive others and level of satisfaction participants’ have with their support |
|
| 22 | Perceived Social Support Scale (PSSS) |
| Perceived social support | The 12-item version of the PSSS measures an individual’s perceptions of the social support and emotional closeness with peers, families and other interpersonal relations |
|
| 23 | Multidimensional Social Support Inventory |
| Perception of social support | The instrument was originally developed to assess the five domains of social support among minority women with HIV/AIDS in the USA |
|
| 24 | Medical Outcomes Study – Social Support Scale |
| Perceived social support | The scale measures the perceived social support for patients living with chronic illness |
|
| 25 | 10-item form of the HIV Stigma Scale (HSS) |
| Stigma | The revised 10-item version of the HSS measures stigma as a construct in HIV positive patients |
|
| 26 | Rosenberg Self-Esteem Scale (RSE) |
| Self-esteem | The RSE is a 10-item scale designed to evaluate global self-esteem |
|
| 27 | Short form Health Survey (SF-36) |
| Physical and psychosocial functioning (Quality of life) | A psychometrically validated questionnaire with 36-items divided among eight scales: Physical Functioning, Role-physical Functioning, Bodily Pain, General Health Perceptions, Vitality, Social Functioning, Role-emotional Functioning and Mental Health. |
|
| 28 | Short Form Health Survey (SF-12) |
| Physical and Psychosocial functioning (Quality of life) | This survey is the validated and short version of the SF-36 used for assessing health status. It is composed of 12 items that provide measures of Physical Health (PCS) and Mental Health (MCS), | |
| 29 | Multiple Sclerosis Quality of Life (MSQOL-54) |
| MS-related quality of life | The 54-item questionnaire measures quality of life using 12 subscales: physical function, role limitations-physical, role limitations-emotional, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, overall quality of life and sexual function. |
|
| 30 | Patient Self-Advocacy Scale (PSAS) |
| Self-advocacy | The scale assesses three dimensions of patient-provider interactions: (1) education, (2) assertiveness (3) nonadherence. |
|
| 31 | 15-item Impact of Event Scale |
| Intrusive and Avoidant thought | The scale assesses subjective distress resulting from exposure to stressful life situations. |
|
| 32 | Ahrens scale |
| Attributional belief | The 30-item scale measures attributional belief, that is, internal attribution and external attribution. |
|
| 33 | Junk and Junk, questionnaire |
| Life events | The scale assesses 70 stressful events that had occurred in the past 6, 12 or more months |
|
Physical, psychological, affective and social outcomes.
| Study | Physical outcome | Affective outcome | Psychological outcome | Social outcome | ||||
|---|---|---|---|---|---|---|---|---|
|
| + | Pain, C-reactive protein. | ++ | HADS-D | 0 | HAD-A. | / | |
| 0 | ESR, HAQ. | + | CSQ | |||||
| ++ | RAI | |||||||
|
| ++ | MFIS, PES, MSQOL physical health, PSQI. | ++ | BDI-II | + | STAI. | ++ | PSSS |
| ++ | MSQOL mental health, RSA. | |||||||
|
| 0 | HbA1c. | + | BDI | + | Quality of Coping. | / | |
| ++ | Denial. | |||||||
| 0 | Attributional belief. | |||||||
| Visschedijk et al. (2004) | + | SF-36 (vitality subscale). | / | 0 | SF-36 (Mental health subscale). | / | ||
| 0 | Disability and Impact profile (Mobility and self-care). | + | Disability and Impact profile (Psychological status). | |||||
|
| + | HbA1c. | / | HADS-D. | / | HADS-A, SF-12. | / | |
|
| 0 | SF-12 (physical health). | + | PANAS | ++ | SF-12 (mental health), LOT-R. | / | |
| 0 | CES-D-10. | |||||||
|
| / | / | PHQ-9. | / | AAQ, HCSD. | / HSS | ||
|
| / | / | ++ | Intolerance to uncertainty, ACHC-MS. | / | |||
| + | GAD-7 | |||||||
|
| 0 | CD4 and viral load. | + | DES. | ++ | Impact of Event Scale | / | |
| ++ | Symptom severity. | 0 | CES-D. | |||||
|
| / | ++ | PHQ-9. | ++ | BASE-6, distress and coping. | ++ | Social support | |
|
| / | + | CES-D. | + | Illness uncertainty scale. | + | Social support | |
| 0 | Patient Self-Advocacy Scale. | |||||||
|
| / | 0 | CES-D | + | Brief COPE. | 0 | Multidimensional Social Support Inventory | |
| 0 | Rosenberg Self-Esteem Scale. | |||||||
No test of significance; 0: No statistically significant improvement; +: Conditionally significant (only significant at some follow-up point or significant improvement for both control/treatment groups or only significant in some dimensions of the scale but not others); ++: Statistically significant; /: Not reported;
Meaning of the abbreviations used here can be found in Table 5.